Boundless Bio, Inc. (BOLD)
NASDAQ: BOLD · Real-Time Price · USD
1.010
-0.060 (-5.61%)
Jun 27, 2025, 4:00 PM - Market closed
Boundless Bio Stock Forecast
Stock Price Forecast
According to 2 professional analysts, the 12-month price target for Boundless Bio stock ranges from a low of $3.00 to a high of $5.00. The average analyst price target of $4.00 forecasts a 296.04% increase in the stock price over the next year.
Price Target: $4.00 (+296.04%)
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for Boundless Bio stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Jan '25 | Feb '25 | Mar '25 | Apr '25 | May '25 | Jun '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 0 | 0 | 0 | 0 | 0 | 1 |
| Buy | 2 | 2 | 2 | 2 | 0 | 0 |
| Hold | 1 | 1 | 1 | 1 | 2 | 2 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 3 | 3 | 3 | 3 | 2 | 3 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Initiates $5 | Strong Buy | Initiates | $5 | +395.05% | Jun 2, 2025 |
| Leerink Partners | Leerink Partners | Buy → Hold Downgrades $15 → $3 | Buy → Hold | Downgrades | $15 → $3 | +197.03% | May 28, 2025 |
| Guggenheim | Guggenheim | Strong Buy → Hold Downgrades n/a | Strong Buy → Hold | Downgrades | n/a | n/a | Dec 13, 2024 |
| Leerink Partners | Leerink Partners | Buy Initiates $25 | Buy | Initiates | $25 | +2,375.25% | Apr 22, 2024 |
| Guggenheim | Guggenheim | Strong Buy Initiates $24 | Strong Buy | Initiates | $24 | +2,276.24% | Apr 22, 2024 |
Financial Forecast
Revenue This Year
n/a
Revenue Next Year
n/a
EPS This Year
-3.16
from -3.85
EPS Next Year
-2.96
from -3.16
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | n/a | n/a | n/a |
| Avg | n/a | n/a | n/a |
| Low | n/a | n/a | n/a |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | - | - | - |
| Avg | - | - | - |
| Low | - | - | - |
EPS Forecast
| EPS | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | -3.16 | -2.68 | -2.96 |
| Avg | -3.16 | -2.96 | -2.90 |
| Low | -3.17 | -3.24 | -2.81 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | - | - | - |
| Avg | - | - | - |
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.